• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟雾病患者颅内动脉的长链非编码RNA图谱

Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.

作者信息

Mamiya Takashi, Kanamori Fumiaki, Yokoyama Kinya, Ota Akinobu, Karnan Sivasundaram, Uda Kenji, Araki Yoshio, Maesawa Satoshi, Yoshikawa Kazuhiro, Saito Ryuta

机构信息

1Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya.

2Department of Biochemistry, Aichi Medical University School of Medicine, and.

出版信息

J Neurosurg. 2022 Jul 29;138(3):709-716. doi: 10.3171/2022.5.JNS22579. Print 2023 Mar 1.

DOI:10.3171/2022.5.JNS22579
PMID:35907193
Abstract

OBJECTIVE

Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive stenosis of the internal carotid artery (ICA) and secondary formation of collateral vessels. Revascularization surgery is performed in patients with MMD to prevent stroke; however, the pathogenesis of MMD remains unknown. Recently, long noncoding RNAs (lncRNAs) have been found to play a key role in gene regulation and are implicated in various vascular diseases. However, the lncRNA expression profile in MMD lesions has not been investigated. In this study the authors aimed to determine the characteristics of lncRNA expression in MMD lesions.

METHODS

The authors collected microsamples of the middle cerebral artery (MCA) from patients with MMD (n = 21) and patients with control conditions (n = 11) who underwent neurosurgical treatment. Using microarray experiments, the authors compared the profiles of lncRNA expression in the MCAs of the MMD and control patient groups and identified differentially expressed lncRNAs (fold change > 2, q < 0.05). In addition, the neighboring coding genes, whose transcription can be regulated in cis by the identified differentially expressed lncRNAs, were investigated and Gene Ontology (GO) analysis was applied to predict associated biological functions.

RESULTS

The authors detected 308 differentially expressed lncRNAs (fold change > 2, q < 0.05), including 306 upregulated and 2 downregulated lncRNAs in the MCA from patients with MMD. Regarding the prediction of biological function, GO analyses with possible coding genes whose transcription was regulated in cis by the identified differentially expressed lncRNAs suggested involvement in the antibacterial humoral response, T-cell receptor signaling pathway, positive regulation of cytokine production, and branching involved in blood vessel morphogenesis.

CONCLUSIONS

The profile of lncRNA expression in MMD lesions was different from that in the normal cerebral artery, and differentially expressed lncRNAs were identified. This study provides new insights into the pathophysiology of MMD.

摘要

目的

烟雾病(MMD)是一种罕见的脑血管疾病,其特征为颈内动脉(ICA)进行性狭窄并继发侧支血管形成。烟雾病患者需进行血管重建手术以预防中风;然而,烟雾病的发病机制仍不清楚。最近,长链非编码RNA(lncRNAs)被发现可在基因调控中发挥关键作用,并与多种血管疾病有关。然而,尚未对烟雾病病变中的lncRNA表达谱进行研究。在本研究中,作者旨在确定烟雾病病变中lncRNA表达的特征。

方法

作者收集了接受神经外科治疗的烟雾病患者(n = 21)和对照患者(n = 11)大脑中动脉(MCA)的微量样本。通过微阵列实验,作者比较了烟雾病患者组和对照患者组MCA中lncRNA的表达谱,并鉴定了差异表达的lncRNAs(倍数变化> 2,q < 0.05)。此外,研究了其转录可由鉴定出的差异表达lncRNAs顺式调控的相邻编码基因,并应用基因本体(GO)分析来预测相关的生物学功能。

结果

作者在烟雾病患者的MCA中检测到308个差异表达的lncRNAs(倍数变化> 2,q < 0.05),其中包括306个上调的lncRNAs和2个下调的lncRNAs。关于生物学功能的预测,对其转录由鉴定出的差异表达lncRNAs顺式调控的可能编码基因进行的GO分析表明,它们参与抗菌体液反应、T细胞受体信号通路、细胞因子产生的正调控以及参与血管形态发生的分支。

结论

烟雾病病变中lncRNA的表达谱与正常脑动脉不同,并鉴定出了差异表达的lncRNAs。本研究为烟雾病的病理生理学提供了新的见解。

相似文献

1
Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.烟雾病患者颅内动脉的长链非编码RNA图谱
J Neurosurg. 2022 Jul 29;138(3):709-716. doi: 10.3171/2022.5.JNS22579. Print 2023 Mar 1.
2
Construction and Comprehensive Analysis of Dysregulated Long Noncoding RNA-Associated Competing Endogenous RNA Network in Moyamoya Disease.构建并综合分析烟雾病失调长链非编码 RNA 相关竞争性内源性 RNA 网络。
Comput Math Methods Med. 2020 Jun 13;2020:2018214. doi: 10.1155/2020/2018214. eCollection 2020.
3
Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair.烟雾病患者颅内动脉的全转录组分析显示免疫反应上调,氧化磷酸化和DNA修复下调。
Neurosurg Focus. 2021 Sep;51(3):E3. doi: 10.3171/2021.6.FOCUS20870.
4
Long Noncoding RNAs and Their Regulatory Network: Potential Therapeutic Targets for Adult Moyamoya Disease.长链非编码RNA及其调控网络:成人烟雾病的潜在治疗靶点
World Neurosurg. 2016 Sep;93:111-9. doi: 10.1016/j.wneu.2016.05.081. Epub 2016 Jun 4.
5
LncRNA-mRNA Co-expression Profiles Relative to Vascular Remodeling in Moyamoya Patients Without RNF213 Mutation.与 RNF213 突变无关的烟雾病患者血管重构相关的长链非编码 RNA-mRNA 共表达谱。
World Neurosurg. 2022 Feb;158:e880-e888. doi: 10.1016/j.wneu.2021.11.104. Epub 2021 Nov 27.
6
Integrated Analysis of LncRNA-mRNA Co-Expression Profiles in Patients with Moyamoya Disease.脑底异常血管网病患者 lncRNA-mRNA 共表达谱的综合分析。
Sci Rep. 2017 Feb 8;7:42421. doi: 10.1038/srep42421.
7
Expression profile of long noncoding RNAs in human cerebral aneurysms: a microarray analysis.人类颅内动脉瘤中长链非编码 RNA 的表达谱:一项微阵列分析。
J Neurosurg. 2017 Nov;127(5):1055-1062. doi: 10.3171/2016.9.JNS16839. Epub 2016 Dec 23.
8
Metabolic Adjustments by LncRNAs in Peripheral Neutrophils Partly Account for the Complete Compensation of Asymptomatic MMD Patients.长链非编码 RNA 在周围血中性粒细胞中的代谢调控部分解释了症状性 MMD 患者的完全代偿。
CNS Neurol Disord Drug Targets. 2020;19(4):306-317. doi: 10.2174/1871527319666200618150827.
9
Circular RNA profiling of neutrophil transcriptome provides insights into asymptomatic Moyamoya disease.环状 RNA 谱分析中性粒细胞转录组可深入了解无症状性烟雾病。
Brain Res. 2019 Sep 15;1719:104-112. doi: 10.1016/j.brainres.2019.05.033. Epub 2019 May 24.
10
Contralateral acute vascular occlusion following revascularization surgery for moyamoya disease.烟雾病血管重建术后对侧急性血管闭塞。
J Neurosurg. 2019 Dec 1;131(6):1702-1708. doi: 10.3171/2018.8.JNS18951. Epub 2018 Dec 14.

引用本文的文献

1
Characterization of moyamoya disease molecular subtypes through disulfidptosis‑related genes and immune landscape analysis.通过二硫键介导的细胞焦亡相关基因和免疫景观分析对烟雾病分子亚型进行表征
Exp Ther Med. 2025 Feb 14;29(4):74. doi: 10.3892/etm.2025.12824. eCollection 2025 Apr.
2
Proteomics and digital subtraction angiography approaches reveal CDH18 as a potential target for therapy of moyamoya disease.蛋白质组学和数字减影血管造影方法显示 CDH18 是治疗烟雾病的潜在靶点。
Biol Direct. 2024 Sep 5;19(1):76. doi: 10.1186/s13062-024-00522-w.
3
Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives.
对表观遗传学在烟雾病中调节作用的见解:当前进展与未来展望。
Mol Ther Nucleic Acids. 2024 Jul 19;35(3):102281. doi: 10.1016/j.omtn.2024.102281. eCollection 2024 Sep 10.
4
Comprehensive Analysis and In Vitro Verification of Endothelial-Mesenchymal Transition-Related Genes in Moyamoya Disease.烟雾病中内皮-间充质转化相关基因的综合分析及体外验证
Mol Neurobiol. 2025 Feb;62(2):2515-2529. doi: 10.1007/s12035-024-04423-x. Epub 2024 Aug 12.
5
Angiopoietin-2 associates with poor prognosis in Moyamoya angiopathy.血管生成素-2 与烟雾病不良预后相关。
Ann Clin Transl Neurol. 2024 Jun;11(6):1590-1603. doi: 10.1002/acn3.52076. Epub 2024 Apr 24.
6
Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS).烟雾病的多组学和血液生物标志物:烟雾病组学图谱(MOYAOMICS)方案
Chin Neurosurg J. 2024 Feb 8;10(1):5. doi: 10.1186/s41016-024-00358-3.
7
Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.烟雾病及相关血管疾病中血管生成与炎症的分子和细胞生物学的生理及病理生理机制
Front Neurol. 2023 May 16;14:661611. doi: 10.3389/fneur.2023.661611. eCollection 2023.